Corvus Pharmaceuticals Inc buy BiotechBee
Start price
08.09.24
/
50%
€3.72
Target price
31.08.27
€5.00
Performance (%)
88.71%
End price
14.12.24
€7.02
Summary
This prediction ended on 14.12.24 with a price of €7.02. With a performance of 88.71% the BUY prediction by BiotechBee was a big success. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Corvus Pharmaceuticals Inc | -18.779% | -18.779% | 320.583% |
| iShares Core DAX® | -1,50 % | 7,70 % | 5,24 % |
| iShares Nasdaq 100 | 1,38 % | 16,28 % | 36,09 % |
| iShares Nikkei 225® | -1,99 % | 13,11 % | 40,18 % |
| iShares S&P 500 | 0,35 % | 10,82 % | 26,47 % |
According to BiotechBee what are the pros and cons of Corvus Pharmaceuticals Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year